Literature DB >> 29432010

Cybastacines A and B: Antibiotic Sesterterpenes from a Nostoc sp. Cyanobacterium.

Alfredo H Cabanillas1, Víctor Tena Pérez1, Santiago Maderuelo Corral2, Diego Fernando Rosero Valencia2, Antera Martel Quintana3, Montserrat Ortega Doménech2, Ángel Rumbero Sánchez1.   

Abstract

Cybastacines A (1) and B (2) were discovered as a novel pentacyclic sesterterpenoid-alkaloid skeleton structure, with a guanidinium group. These molecules were isolated from a Nostoc sp. cyanobacterium collected in the Canary Islands. Their structures were elucidated primarily by a combination of spectroscopic analyses and X-ray diffraction. These compounds showed antibiotic activities against several clinically relevant bacterial strains.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29432010     DOI: 10.1021/acs.jnatprod.7b00638

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

Review 1.  Cyanobacterial secondary metabolites towards improved commercial significance through multiomics approaches.

Authors:  Shaloo Verma; Shobit Thapa; Nahid Siddiqui; Hillol Chakdar
Journal:  World J Microbiol Biotechnol       Date:  2022-04-29       Impact factor: 3.312

Review 2.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

3.  New Sesterterpenoids from Salvia mirzayanii Rech.f. and Esfand. Stereochemical Characterization by Computational Electronic Circular Dichroism.

Authors:  Foroogh Mirzania; Mahdi Moridi Farimani; Yaghoub Sarrafi; Samad Nejad Ebrahimi; Jakob Troppmair; Marcel Kwiatkowski; Hermann Stuppner; Mostafa Alilou
Journal:  Front Chem       Date:  2022-01-20       Impact factor: 5.221

Review 4.  Phycochemistry and bioactivity of cyanobacterial secondary metabolites.

Authors:  Rupanshee Srivastava; Rajesh Prajapati; Tripti Kanda; Sadhana Yadav; Nidhi Singh; Shivam Yadav; Rajeev Mishra; Neelam Atri
Journal:  Mol Biol Rep       Date:  2022-09-26       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.